Health+Wellness

FDA panel urges to keep Controversial Diabetes Drug “Avandia” on the market

By  

Federal health experts are recommending changes to safety restrictions on the controversial diabetes pill Avandia, in light of a new analysis suggesting that the drug may not increase the risk of heart attack as much as previously thought.

The FDA has been reconsidering its approval of Avandia, which was the world’s No. 1 diabetes drug until research showed it could raise the risk of heart attacks and other heart dangers. Since then, its use has been heavily restricted and prescriptions have plummeted, and the FDA wanted to know if it was worth even keeping the drug on the market. (source)

Dr. Suzanne Steinbaum, Preventive Cardiologist at Lenox Hill Hospital in New York City joins UTTM to discuss the possible lifting of restrictions surrounding the use of GlaxoSmithKline’s diabetes drug Avandia:

Thirteen members of a 26-memberFood and Drug Administrationadvisory committee voted to soften the restrictions on the drug, Avandia, which has gone from being one of the industry’s biggest blockbusters to a marginalized drug used by a few thousand people. (source)

If you enjoyed this video, and you’re interested in learning wellness tips that are customized for women over 50, you'll LOVE HealthQueens+, the Most Powerful Way to Lose Weight Age 50+ and Keep It Off For Good, So You Can Be Around to See Your Grandkids Grow Up (Instead of Becoming a Burden to Your Family)

Learn More

About:

More like this:
Health+Wellness
Woman over 50? Join Us!

We ♥ your privacy

" FDA panel urges to keep Controversial Diabetes Drug “Avandia” on the market "

CLOSE